期刊文献+

急性冠脉综合征患者血清E-选择素和白细胞CD11b/CD18表达的研 被引量:3

Serum levels of soluble E-selectin and expression of CD11b/CD18 on leukocytes in patients with acute coronary syndrome
原文传递
导出
摘要 目的 观察血清E 选择素水平、中性粒细胞及单核细胞CD11b/CD18表达在急性冠脉综合征 (ACS)患者中的变化 ,探讨其与斑块稳定性的关系。方法  3 0例ACS患者 (ACS组 )、2 4例稳定型心绞痛患者 (SA组 ) ,3 0例冠状动脉造影阴性者作为对照组。酶联免疫吸附法检测E 选择素 ,流式细胞仪检测CD11b/CD18的表达。结果 血清E 选择素水平、中性粒细胞和单核细胞膜CD11b/CD18的表达ACS组显著高于SA组 (P <0 .0 1)和对照组 (P <0 .0 1)。结论 ACS患者血清E 选择素水平。 Objective Observing the levels of serum soluble E-selectin and expression of CD11b/CD18 on neutrophils and monocytes in patients with acute coronary syndrome to investigate the relationship with stability of plaques.Methods 30 patients with acute coronary syndrome(ACS),24 patients with stable angina pectoris(SAP),30 coronary angiography negative as controls.We measure the serum level of soluble E-selectin by means of enzyme linked immunosorbent assay (ELISA) and the expression of CD11b/CD18 on neutrophils and monocytes by flow cytometry.Results The serum levels of soluble E-selectin and expression of CD11b/CD18 on neutrophils and monocytes in the ACS group were significantly higher than those in the SAP group(P<0.01)and controls(P<0.01).Conclusion The serum levels of soluble E-selectin and expression of CD11b/CD18 on neutrophils and monocytes in patients with ACS are related with unstability of plaques.
出处 《临床内科杂志》 CAS 北大核心 2004年第2期128-130,共3页 Journal of Clinical Internal Medicine
关键词 冠状动脉综合征 白细胞 E-选择素 抗原 CD11b Acute coronary syndrome Leukocyte E-selectin Antigen,CD11b
  • 相关文献

参考文献1

二级参考文献13

  • 1Buja LM, Willerson JT. Clinicopathologic correlates of acute ischemic heart disease syndromes. Am J Cardiol,1981,47:343-356.
  • 2Van der Wal AC, Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.Circulation,1994,89:36-44.
  • 3Jang YS, Lincoff AM, Plow EF, et al. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol,1994,24:1591-1601.
  • 4Lehr H, Hubner C, Nolte D, et al. Oxidatively modified human low density lipoprotein stimulates leukocyte adherence to the microvascular endotheliumin vivo. Res Exp Med,1991,191:85-90.
  • 5Kim RS, LaBella FS. Comparison of analytical methods for monitoring auto-oxidation profiles of authentic lipids. J Lipid Res,1987,28:1110-1117.
  • 6Sinikka K, Enockson C, Lopes-virella MF, et al. Preparation of a human standard for determination of the levels of antibodies to oxidatively modified low density lipoproteins. Clin And Diagno Lab Immuno,1998,5:817-822.
  • 7Pigott R, Dillon LP, Hemingway IH, et al. Soluble form of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun,1992,187:584-589.
  • 8Palinski W, Yla-Herttuala S, Rosenfeld ME, et al. Antisera and monoclonal antibodies specific for epitopes generated during the oxidative modification of low density lipoprotein.Arteriosclerosis,1990,10:325-333.
  • 9Danial Steinberg. Lewis a conner memorial lecture-oxidative modification of LDL and atherogenesis. Circulation, 1997,95:1062-1071.
  • 10Libby P, Geng YJ, Aikawa M, et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol, 1996,7(5):330-335.

共引文献14

同被引文献52

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部